Clarithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Clarithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23016
Buy Now

Clarithromycin Prices June 2023

Product
Category Region Price
Clarithromycin Pharma API North America 257700 USD/MT
Clarithromycin Pharma API Asia Pacific 203200 USD/MT
Clarithromycin Pharma API Europe 260500 USD/MT


In the second quarter of 2023, the price of the clarithromycin the North America reached 257700 USD/MT by June. Similarly, in Asia Pacific, the clarithromycin prices hit 203200 USD/MT in the same month. Europe also saw clarithromycin prices reaching 260500 USD/MT during Q2 2023.

Clarithromycin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled Clarithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of clarithromycin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing clarithromycin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Clarithromycin Price Trend

Clarithromycin Market Analysis

The global clarithromycin market size reached US$ 1.5 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 2.3 Billion, at a projected CAGR of 4.50% during 2023-2032.

  • The rising incidence of respiratory infections across the world is significantly driving the demand for clarithromycin. Conditions like bronchitis, pneumonia, and sinusitis have seen a significant rise due to the factors like pollution, smoking, and growing geriatric population that is more vulnerable to such infections. According to a data published by the World Health Organization, seasonal influenza affects around a billion people yearly along with 3 million to 5 million experiencing severe illness. It leads to 290,000 to 650,000 respiratory deaths every year. In developing countries, 99% of deaths from influenza related lower respiratory tract infections occur in children under 5. Clarithromycin is a broad-spectrum macrolide antibiotic which is highly effective in treating these bacterial infections. Its ability to target a wide array of pathogen makes it a highly sought after choice among healthcare providers, thereby propelling its market growth.
  • Rising investments by pharmaceutical companies in research and development (R&D) significantly propels the clarithromycin market growth. These investments mainly focus on discovering new therapeutic indications and enhancing existing formulations to improve its efficacy and patient compliance. For instance, in 2022, Pfizer invested $120 million in its Kalamazoo Facility to produce its COVID-19 oral treatment PAXLOVID. In line with this, the ongoing research aims to combat antibiotic resistance, further ensuring clarithromycin remains a viable treatment option for respiratory infections. These innovations not only enhance the drug’s clinical utility, but also opens new opportunities for the market growth.
  • The growing geriatric population is also contributing to the rising demand for clarithromycin. As people age, their immune systems become less robust, which makes them more susceptible to respiratory infection and bacterial infections. According to data published by the World Health Organization, by year 2030, 1 in 6 people across the world will be aged 60 years or above. The proportion of global population over 60 years old is expected to nearly double from 12% in 2015 to 22% in 2050 with 2.1 billion people aging over 60 years or above by 2050. The elderly are at higher risk for conditions like pneumonia and bronchitis, which often require antibiotic treatment. Clarithromycin is a broad-spectrum antibiotic which is frequently prescribed for these infections due to its effectiveness against a wide array of pathogens. The rising number of elderly individuals across the world drives the demand for reliable antibiotics like clarithromycin to manage these health challenges effectively.

Clarithromycin News

The report covers the latest developments, updates, and trends impacting the global clarithromycin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in clarithromycin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the clarithromycin industry:

  • In 2024, Abbott launched GLP Systems Track, an innovative automation solution to support high-volume laboratory needs in India. The system, installed in Chennai, Bengaluru, Ahmedabad, and Srinagar, reduces manual steps by 80%, minimizing errors and improving turnaround time. The technology aims to increase testing capabilities, reduce operational costs, and enhance workflow and productivity, ultimately improving patient care and safety.
  • In 2024, AbbVie and Gilgamesh Pharmaceuticals collaborated to develop next-generation therapies for psychiatric disorders. The collaboration will focus on leveraging AbbVie's psychiatry expertise and Gilgamesh's innovwkative research platform to discover novel neuroplastogens. Under the agreement, AbbVie will lead development and commercialization activities if the option is exercised. Gilgamesh will receive an upfront payment of $65 million and is eligible for up to $1.95 billion in fees and milestones, as well as royalties from net sales.

Product Description

Clarithromycin is a broad-spectrum macrolide antibiotic commonly used to treat various bacterial infections. It is particularly effective against respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as skin infections, ear infections, and Helicobacter pylori-associated peptic ulcers. Clarithromycin works by inhibiting bacterial protein synthesis, thereby stopping the growth and reproduction of bacteria. Its mechanism of action involves binding to the 50S ribosomal subunit of the bacteria, blocking the translocation of peptides. The antibiotic is available in both immediate-release and extended-release formulations, allowing flexibility in dosing and enhancing patient compliance. Clarithromycin is also used in combination with other medications to treat specific infections, like H. pylori eradication in peptic ulcer disease. It is generally well-tolerated, but potential side effects can include gastrointestinal disturbances, headaches, and taste disturbances. Due to its efficacy and versatility, clarithromycin is a widely prescribed antibiotic in clinical practice.

Regional Coverage

The report provides a detailed analysis of the clarithromycin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends.

Global Clarithromycin Price

The report offers a holistic view of the global clarithromycin pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Clarithromycin Price

European clarithromycin prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed clarithromycin price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Clarithromycin Price

The analysis of clarithromycin prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on clarithromycin prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Clarithromycin Price

The report explores the clarithromycin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on clarithromycin prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Clarithromycin Price

The clarithromycin pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed clarithromycin prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Clarithromycin Price

The analysis of clarithromycin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Clarithromycin
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of clarithromycin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting clarithromycin price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the clarithromycin industry. 

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Clarithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More